Scan to downloadJCR Pharmaceuticals Co.,Ltd. (4552) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-10-29 | Earnings Release | Consolidated Financial Results for the Six Months ended September 30, 2026 (FY2026) (Japanese standard) | |
| 2026-10-29 | Presentation Materials | FY2026 Second Quarter Results Briefing Session Material | |
| 2026-10-02 | — | Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for JR-141 in the United States, Europe, and Latin America | |
| 2026-07-30 | Presentation Materials | FY2026 First Quarter Results Briefing Session Material | |
| 2026-07-30 | Earnings Release | Consolidated Financial Results for the Three Months ended June 30, 2026 (FY2026) (Japanese standard) | |
| 2026-07-22 | Treasury Shares | Notice Regarding the Completion of Payment for the Disposition of Treasury Stock as Restricted Stock Compensation | |
| 2026-07-15 | — | JCR Pharmaceuticals Announces Development Plan in Japan for Givinostat for Duchenne Muscular Dystrophy |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.